Lifespan

mTOR is indeed a central switch that drives cells to grow, and chronic overactivation contributes to ageing; autophagy, one of the body's protective mechanisms, also declines when mTOR is overactive. However, the research in our sources focuses on excessive mTOR activity in general, not specifically on animal protein or branched-chain amino acids as the culprit. Whether you can genuinely slow ageing by eating less animal protein has not yet been proven in humans; the best-supported ways to keep mTOR in check are eating less and exercising more.

The direction of the claim is correct: an unhealthy diet is associated with chronic inflammation, disruptions to the gut microbiome, and accelerated cellular ageing. This association has been demonstrated consistently across multiple studies, although the research is largely observational and mechanistic rather than establishing a firm chain of cause and effect. The available studies say little about blood sugar levels as a separate consequence of a poor diet, so that part of the claim is less well supported. The claim is therefore broadly accurate, but comes across as somewhat more definitive than the moderate evidence warrants.

The claim states that sirtuins, activated through exercise, fasting, or resveratrol, improve the functioning of mTOR and AMPK, but the research paints a different and more nuanced picture. Sirtuins may influence ageing processes in animal and laboratory studies, but convincing human data are entirely lacking. Moreover, exercise and fasting are themselves the direct activators of AMPK, while mTOR is actually suppressed by reduced food intake and exercise rather than "improved" via sirtuins. The proposed relationship, in which sirtuins act as an intermediary that upgrades the functioning of mTOR and AMPK, is not supported by the available research.

Metformin does indeed work through multiple interrelated mechanisms, including effects on cellular energy balance that are linked to AMPK. However, the picture is more nuanced than the claim suggests: at normal doses, disruptions in energy balance and inhibition of a specific liver enzyme play the greatest role, while the mitochondrial respiratory chain only appears to become relevant at higher concentrations. The claim that metformin improves insulin sensitivity is correct as a general direction, but the primary effect is the suppression of glucose production in the liver, not a direct improvement of insulin sensitivity as the main mechanism. Moreover, exactly how the various mechanisms interact has not yet been fully worked out.

Multiple human studies confirm that the gut flora changes with age and that a diverse flora is associated with healthier ageing. The first part of the claim, a decrease in diversity, is supported by observational research. The second part, a shift towards specifically pro-inflammatory bacterial species, goes a step further than the available evidence firmly establishes: the research is largely associative and shows rather a reduction in anti-inflammatory species than a proven increase in harmful ones. Furthermore, cause and effect have not yet been demonstrated.

The link between chronic low-grade inflammation and accelerated cellular ageing is well established and consistent with the research evidence. The association with diabetes and cardiovascular disease is also supported by multiple studies. For Alzheimer's disease, however, the connection is biologically plausible but causal evidence in humans has not yet been fully demonstrated. The claim is therefore largely correct, but presents the evidence for all three conditions as equally strong, whereas the evidence for dementia is less robust than it is for diabetes and heart disease.

Semaglutide did indeed show a measurable slowing of biological aging in research, but the study it is based on was small, conducted in HIV patients, and not primarily designed to measure aging. The figure of 9% cannot be substantiated: the effects found were expressed as a difference of two to five years on aging clocks, not as a percentage of the rate of aging. Whether this result also applies to people without HIV has not yet been tested.

Our answer on epigenetic reprogramming confirms that animal and cell culture studies show that ageing patterns can be reversed, which supports the direction of the claim. Research on retinal nerve cells in animal models fits within that broader picture. Nevertheless, the claim goes further than the available evidence justifies: evidence in humans is entirely lacking, and the biggest unresolved problem remains safety, as excessive reprogramming increases the risk of tumour formation. The claim sounds more definitive than the current state of research allows.

Intensive strength training measurably increases bone density in people with low bone mass, and high training intensity appears to yield the greatest benefit. The claim goes beyond the evidence on two points: that specifically 'impact' training makes the decisive difference cannot be substantiated, and that bone density of both the hip and the spine increases in postmenopausal women with osteopenia or osteoporosis has not yet been established in randomised studies. Furthermore, it has not been proven that strength training reduces the number of fractures.

Exercising more does reduce your risk of dying, and the benefit levels off beyond a certain amount, but the specific thresholds mentioned in the claim do not match what the research shows. The available evidence points to 450 to 750 minutes of moderate activity per week as the point at which further gains diminish, not the 300 to 600 minutes (5 to 10 hours) the claim suggests. The direction is correct, but the precise range of 2.5 to 5 hours of vigorous activity or 5 to 10 hours of moderate activity as the optimum for maximum risk reduction is not supported by the research.

There are tentative indications that meditation programmes can increase telomerase activity, and an effect on inflammatory markers through stress reduction is plausible. However, the step to specific biomarkers such as 8-oxodG and IL-6, after exactly twelve weeks of yoga combined with meditation, goes beyond what the available research supports. The studies showing positive signals are small and vary in design, and whether yoga as an addition makes a difference over meditation alone has not been demonstrated. The direction of the claim is not implausible, but the combination of specific biomarkers, a precise duration, and the pairing of yoga with meditation has not yet been convincingly tested.

Research does show that muscle strength declines significantly after middle age, but the findings specifically point to a loss of 3 to 4% per year in leg strength after the age of fifty, not 2 to 4% already from the age of forty. Furthermore, this refers to strength, whereas the claim speaks of muscle power, which is a subtly different concept. The direction of the claim is correct, but the starting age and the precise percentage differ from what the research shows.

A higher resting heart rate is indeed associated with an increased risk of death, and this relationship has been demonstrated independently of other risk factors. The direction of the claim is therefore correct. However, the precise figure of 15 to 20% per 10 beats per minute cannot be firmly established on the basis of available research: studies do show an elevated risk above certain thresholds, but a quantified linear relationship of this precision per increment of 10 beats has not been established. Moreover, research suggests that a very low resting heart rate in older age is not necessarily a good sign either, which makes the relationship less straightforward than the claim implies.

Research shows that the greatest health gains begin with even a modest amount of physical activity, so the direction of the claim is correct. However, the studies in our knowledge base use 150 minutes per week as the reference point for a significant reduction in mortality risk, not 75 minutes. Whether that halved amount is already sufficient for a measurable benefit on both premature death and cardiovascular disease cannot be firmly established based on the available evidence.

Research does indeed show that more physical activity lowers the risk of death, but that the gains diminish as you do more. That aligns with the direction of the claim. However, the specific ranges mentioned (2.5 to 4.5 hours, and more than 10 hours as risk-increasing) cannot be substantiated based on the available research: studies suggest the point at which benefits level off is closer to 450 to 750 minutes per week, and an increased mortality risk above 10 hours has not been demonstrated. That overtraining can be harmful is documented, but this applies to elite athletes who train extremely hard without adequate recovery, not to an increased mortality risk from recreational exercise of more than 10 hours per week.